FDA Cell therapies and tissue-based products: a public workshop on generating scientific evidence to facilitate development (from Catapult’s regulatory round-up for December 2024)
The FDA’s CBER OTP is hosting a virtual scientific public workshop on 25th February 2025, titled “Cell Therapies and Tissue-based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development.” The purpose of the workshop...